Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Early Access and the Potential Cost Savings by the Compassionate Use of Onco-haematological Drugs: Results from the Italian Study Compass-O.
Dell'Anno I, Dondi L, Esposito I, Mascolo A, Capuano A, de Marchi G, Cristinziano A, Tarantino D, Pani M, Masini C, Donati C, Rossin E, Serafini A, Bagaglini G, Bonanni G, Gregori T, Cavaliere A, Matocci R, D'Arpino A, Martini N, Piccinni C. Dell'Anno I, et al. Among authors: masini c. Clin Drug Investig. 2024 Aug;44(8):577-586. doi: 10.1007/s40261-024-01381-z. Epub 2024 Jul 20. Clin Drug Investig. 2024. PMID: 39031332
Hydroxychloroquine as Prophylaxis for COVID-19: A Review.
Monti M, Vertogen B, Masini C, Donati C, Lilli C, Zingaretti C, Musuraca G, De Giorgi U, Cerchione C, Farolfi A, Cortesi P, Viale P, Martinelli G, Nanni O. Monti M, et al. Among authors: masini c. Front Pharmacol. 2020 Dec 3;11:605185. doi: 10.3389/fphar.2020.605185. eCollection 2020. Front Pharmacol. 2020. PMID: 33343376 Free PMC article. Review.
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Nanni O, Viale P, Vertogen B, Lilli C, Zingaretti C, Donati C, Masini C, Monti M, Serra P, Vespignani R, Grossi V, Biggeri A, Scarpi E, Galardi F, Bertoni L, Colamartini A, Falcini F, Altini M, Massa I, Gaggeri R, Martinelli G. Nanni O, et al. Among authors: masini c. Trials. 2020 Jul 31;21(1):689. doi: 10.1186/s13063-020-04527-4. Trials. 2020. PMID: 32736597 Free PMC article.
Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination with 5-Fluorouracil in the FOLFIRI Regimen.
Passardi A, Monti M, Donati C, Foca F, Pagan F, Rapposelli I, Ruscelli S, Bartolini G, Valgiusti M, Matteucci L, Sullo F, Sbaffi S, Crudi L, Frassineti GL, Masini C. Passardi A, et al. Among authors: masini c. Oncologist. 2021 Aug;26(8):e1314-e1319. doi: 10.1002/onco.13762. Epub 2021 Apr 22. Oncologist. 2021. PMID: 33764600 Free PMC article.
The challenge of sustainability in healthcare systems: economic and organizational impact of subcutaneous formulations for rituximab and trastuzumab in onco-hematology.
Altini M, Gentili N, Balzi W, Musuraca G, Maltoni R, Masini C, Galardi F, Bertoni L, Massa I. Altini M, et al. Among authors: masini c. Expert Rev Pharmacoecon Outcomes Res. 2021 Jun;21(3):503-509. doi: 10.1080/14737167.2020.1764353. Epub 2020 May 13. Expert Rev Pharmacoecon Outcomes Res. 2021. PMID: 32403958
Use of the ONCO-TreC electronic diary compared with a standard paper diary to improve adherence to oral cancer therapy in patients with solid and haematological tumours: protocol for a randomised controlled trial.
Passardi A, Serra P, Caffo O, Masini C, Brugugnoli E, Vespignani R, Giardino V, Petracci E, Bartolini G, Sullo F, Anesi C, Dianti M, Eccher C, Piras EM, Gios L, Campomori A, Oberosler V, Forti S. Passardi A, et al. Among authors: masini c. BMJ Open. 2022 Jan 11;12(1):e055814. doi: 10.1136/bmjopen-2021-055814. BMJ Open. 2022. PMID: 35017254 Free PMC article.
163 results